Asset Dedication, LLC Incyte Corp Transaction History

Asset Dedication, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$76.02 - $100.5 $1,976 - $2,613	-26 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$85.07 - $109.69 $2,211 - $2,851	26 New	26 $2,000
Q1 2020 May 05, 2020	SELL	$63.18 - $85.97 $1,642 - $2,235	-26 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$73.04 - $95.72 $1,899 - $2,488	26 New	26 $2,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Dedication, LLC with notifications on news.